"The Challenge of Accessing New Weight Loss Medications in Today's Market"
TL;DR Summary
The new weight loss and diabetes medications, such as semaglutide and tirzepatide, have seen a surge in demand due to their effectiveness, but supply has not kept up. Patients should consult a healthcare provider before considering these medications, as they can have powerful effects and may cause gastrointestinal issues. Some dosages are in short supply, and insurance coverage can be difficult, with out-of-pocket costs reaching $1,000 a month. Not everyone may be suitable for these drugs, and it's important to make a personal decision in consultation with a doctor.
Topics:health#health-medicine#prescription-drugs#semaglutide#side-effects#tirzepatide#weight-loss-medications
- Getting your hands on the new weight loss meds isn't simple WDSU New Orleans
- Multi-billion dollar weight loss drug market causes race to pharmacy FOX 59 Indianapolis
- Most employer health plans don't cover new blockbuster weight loss drugs, but that's going to change CNBC
- Getting your hands on the new weight loss meds isn’t simple. Here are 5 things to know CNN
- Wegovy maker dinged employers for restricting hot weight-loss drugs Business Insider
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
9 min
vs 10 min read
Condensed
95%
1,865 → 89 words
Want the full story? Read the original article
Read on WDSU New Orleans